Group One Trading’s Ambrx Biopharma Inc AMAM Stock Holding History

Group One Trading’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-58,900	Closed	-$839K	–	8224
2023 Q4	$839K	Buy	58,900 +15,900	+37%	+$181K	﹤0.01%	2627
2023 Q3	$495K	Buy	43,000 +17,200	+67%	+$234K	﹤0.01%	2919
2023 Q2	$425K	Buy	25,800 +23,800	+1,190%	+$299K	﹤0.01%	3184
2023 Q1	$17.8K	Buy	+2,000	New	+$10.1K	﹤0.01%	5586

Group One Trading's AMAM Position: Q4 2023 in Review

Group One Trading sold out of Ambrx Biopharma Inc (AMAM) in Q4 2023, closing a stake of 2,155 shares — an estimated $24.5K sold.

Group One Trading first reported a position in AMAM in Q1 2023 and held it in 2 quarters. The position peaked at $29.8K in Q1 2023. 68 funds tracked by Wall St. Rank hold AMAM as of Q4 2023.

Group One Trading reported no remaining Ambrx Biopharma Inc position as of Q4 2023 after selling out during the quarter.
Group One Trading sold 2,155 Ambrx Biopharma Inc shares in Q4 2023, an estimated $24.5K.
Group One Trading first reported a position in Ambrx Biopharma Inc in Q1 2023 and held it in 2 quarters.
Group One Trading's Ambrx Biopharma Inc position peaked at $29.8K in Q1 2023.
68 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.